Lung cancer remains the leading cause of cancer-related death worldwide. Previous studies have shown that the novel KIAA0247 gene potentially targeted by the tumor suppressor p53 may inhibit the development of several cancers. However, the exact function of KIAA0247 in non-small-cell lung cancer (NSCLC) is unknown.
which is associated with transcriptional regulation of certain critical genes; therefore, it is necessary to identify these pro-metastatic genes and investigate their effects in detail.
Notch signaling has been shown to participate in development and cell proliferation, differentiation, and apoptosis, and several studies have shown that deregulation of the Notch pathway is involved in such malignancies as breast cancer and T-cell leukemia. 6 The role of Notch in lung cancer was experimentally shown in a transgenic mouse model, where activated Notch overexpressed in the alveolar epithelium cooperated with the Myc pathway in promoting NSCLC development. 7 Another study indicated that Notch1 suppressed p53-mediated apoptosis through the regulation of p53 stability and was required for the growth of lung adenocarcinoma. 8 Notch signaling is activated by ligand-receptor binding involving five ligands (Delta-like 1, 3, and 4, and Jagged-1 and -2) and four receptors (Notch1-4). Ligand binding induces a conformational change in Notch, leading to the exposure of the S2 site for the sequential cleavage by a protease of the disintegrin and metalloproteinase (ADAM) family and the gamma-secretase complex. As a result, the Notch intracellular domain (NICD) is liberated and translocated to the nucleus 9 where it induces the expression of target oncogenes coding for cyclin D1, c-Myc, p21, p27, nuclear factor-kappa B (NFjB), survivin, slug, and Nanog, 10 which promote carcinogenesis.
KIAA0247 is a novel gene encoding a 303-amino acid single-pass type I membrane protein, which is highly conserved among species.
Although KIAA0247 is not mutated in cancers, it has been suggested to play a role in oncogenesis because of a p53-responsive element found in its promoter region, indicating that KIAA0247 is a prospective target for the tumor suppressor p53. 11 KIAA0247 has also been named DRAGO (drug-activated gene overexpressed) because treatment with certain drugs (cisplatin, alkylating agents, antimetabolites, topoisomerase II inhibitors, taxanes, and nutlin-3) induces its expression in HCT116 p53 +/+ cells but not in HCT116 p53 À/À cells.
11
KIAA0247 overexpression is associated with the therapeutic benefits of 5-fluorouracil, and the presence of KIAA0247 mRNA in fecal samples of colon cancer patients correlates with a more favorable prognosis. 12 In ovarian cancer, advanced-stage tumors express approximately 30% less KIAA0247 mRNA compared to levels in early-stage tumors. 11 Another study showed that KIAA0247 mRNA was downregulated in glioma compared to normal brain tissue, whereas KIAA0247 overexpression suppressed the proliferation and angiogenesis of glioma cell lines and promoted apoptosis through inactivation of the AKT and Stat3 signaling pathways. 13 The KIAA0247 gene is located on human chromosome 14q24.1, which also contains the SERPINA1 gene responsible for a1-antitrypsin deficiency that leads to lung tissue damage, pulmonary emphysema, and lung cancer. 14 However, the biological function of KIAA0247 in lung cancer is currently unclear, and there are no data regarding KIAA0247 expression pattern or its clinical significance in NSCLC. In the present study, we investigated the role of KIAA0247 in NSCLC by examining KIAA0247 mRNA and protein expression in cancer tissues by realtime PCR and immunohistochemistry. We also analyzed the effects of KIAA0247 levels on the proliferation, migration, and invasion of lung cancer cell lines and explored the underlying molecular mechanisms. The intensity of KIAA0247 staining was scored as follows: 0 (no staining), 1 (weak staining), 2 (moderate staining), and 3 (high staining). Percentage scores were assigned as follows: 0 (0%), 1 (1%-30%), 2 (31%-70%), and 3 (71%-100%). The scores of each tumor sample were multiplied to give a final score ranging from 0 to 9;
| MATERIALS AND METHODS
tumor samples with scores >3 were considered to show high KIAA0247 expression, and those with scores ≤3 were considered to show low KIAA0247 expression.
| Immunocytochemistry
Lung cancer cells cultured in 24-well plates for 24 hours were fixed in paraformaldehyde (2%) for 15 minutes, blocked in BSA (5%) for 2 hours, and incubated with the anti-KIAA0247 antibodies (1:100)
for 18 hours and then with a tetramethylrhodamine (TRITC)-conjugated secondary antibody for 2 hours; nuclei were counterstained with DAPI. Cell images were captured using an Olympus FV1000
laser-scanning confocal microscope (Olympus, Tokyo, Japan). 
| Quantitative real-time PCR
All experiments were carried out in triplicate.
| Western blotting
Expression of proteins directly influencing cell migration and invasion [15] [16] [17] [18] [19] and those involved in cell proliferation and cell cycle pro- 
| Statistical analysis
SPSS 16.0 software (SPSS Inc., Chicago, IL, USA) was used for data processing. Survival of NSCLC patients was analyzed using the Kaplan-Meier estimator. 25, 26 Correlations between KIAA0247 expression and clinicopathological features were examined by chisquared test, and differences between cell groups were compared by paired t test. Two-sided P-values <.05 were considered statistically significant.
3 | RESULTS
| Downregulation of KIAA0247 expression has clinical significance
Analysis of KIAA0247 protein expression by immunocytochemistry indicated that KIAA0247 was localized both in the cytoplasm and in the nuclei of NSCLC A549, H292, H1299, H460, H661, and SK-MES-1 cells, as well as in normal bronchial epithelial HBE cells (Figure 1A) . We next examined KIAA0247 protein levels in the same lung cancer cell lines ( Figure 1B ) and quantified relative expression levels. A549 and H1299 cells showed the highest KIAA0247 expression levels, whereas H292 and H661 cells showed the lowest.
Because of the relationship between KIAA0247 and p53, and based on these basal expression levels, A549 and H1299 cells were used for subsequent experiments.
Furthermore, real-time PCR analysis of 35 NSCLC specimens and the corresponding normal tissues indicated that the expression of KIAA0247 mRNA was lower in tumors than in the matched surrounding tissue ( Figure 1C ). This observation was supported by the downregulated expression of KIAA0247 protein in tumors compared to that in adjacent normal lung tissue which showed strong staining, as indicated by immunohistochemistry analysis of 197 paired NSCLC/normal tissue specimens ( Figure 1D ).
We also investigated the relationship between KIAA0247 protein expression and clinical parameters. As shown in Table 2 , KIAA0247 levels negatively correlated with poor differentiation (P < .001), lymph node metastasis (P < .001), and advanced p-TNM stage (P < .001), but did not significantly vary depending on age (P = .865), gender (P = .119), tumor histological type (P = .311), and size (P = .134). Regarding the correlation of KIAA0247 expression with NSCLC prognosis, Kaplan-Meier analysis in adenocarcinoma patients of all grades, stages, genders, smoking history, surgery
T A B L E 2 Association of KIAA0247 expression with clinical and pathological characteristics of NSCLC patients
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Age (years) success, chemotherapy, and radiotherapy showed that high KIAA0247 levels were associated with survival ( Figure 1E ).
| KIAA0247 inhibits migration and invasion of lung cancer cells
As KIAA0247 levels correlated with NSCLC progression, we next explored the biological function of KIAA0247 in lung cancer cells by genetically manipulating KIAA0247 expression. KIAA0247 knockdown with siRNA promoted, whereas KIAA0247 overexpression inhibited, migration and invasion of A549 and H1299 cells compared with control cells, and the difference was statistically significant (Figure 2A) . Consistent with these results, variations in KIAA0247 protein levels affected the expression of proteins involved in cell migration and invasion. Thus, RhoA, RhoC, and MMP9 were upregulated and RhoB was downregulated by KIAA0247 knockdown, F I G U R E 2 Effect of KIAA0247 expression on the migration and invasion of non-small-cell lung cancer (NSCLC) cells. A549 and H1299 cells were transfected with KIAA0247-specific siRNA (si-KIAA0247) or control siRNA, or with a KIAA0247 expression plasmid (p-KIAA0247) or vehicle (control). A, Cell migration analyzed by Transwell migration assay; cells that migrated to the lower chamber were stained with hematoxylin and counted. *P < .05; **P < .01. (i) A549 migration: si-KIAA0247 vs control siRNA, P = .024; p-KIAA0247 vs control, P = .005.
(ii) H1299 migration: si-KIAA0247 vs control siRNA, P = .046; p-KIAA0247 vs control, P = .047. (iii) A549 invasion: si-KIAA0247 vs control siRNA, P = .005; p-KIAA0247 vs control P = .035. (iv) H1299 invasion: si-KIAA0247 vs control siRNA, P = .007; p-KIAA0247 vs control, P = .023. (B,C) Expression of KIAA0247 and cell migration-and invasion-related proteins in transfected (B) A549 and (C) H1299 cells whereas KIAA0247 overexpression caused the opposite effects (Figure 2B,C) . Taken together, these findings show that KIAA0247 suppresses the migration and invasion of lung cancer cells.
| KIAA0247 inhibits growth of lung cancer cells
Next, we analyzed the effect of KIAA0247 expression on the clinically relevant properties of cancer cells, such as colony formation and cell proliferation. In A549 and H1299 cells, KIAA0247 downregulation promoted clone formation, which was inhibited by KIAA0247 upregulation compared with control groups ( Figure 3A) . Consistent with these observations, KIAA0247 knockdown induced cell proliferation, whereas KIAA0247 overexpression reduced cell proliferation as evidenced by the MTT assay ( Figure 3B) , and blocked the cell cycle at the G1/S phase as evidenced by flow cytometry ( Figure 3C ).
Analysis of proteins involved in cell proliferation and cell cycle progression showed that expression of cyclin D1, CDK4, and c-Myc was upregulated and that of p21 was downregulated by KIAA0247 knockdown, whereas KIAA0247 overexpression had the opposite effects ( Figure 3D,E) .
Effect of KIAA0247 expression on colony formation, proliferation, and cell cycle progression of non-small-cell lung cancer (NSCLC) cells. A549 and H1299 cells were transfected with KIAA0247-specific siRNA (si-KIAA0247) or control siRNA, or with a KIAA0247 expression plasmid (p-KIAA0247) or vehicle (control). *P < .05 and **P < . 
| DISCUSSION
Lung cancer, especially NSCLC, remains the leading cause of cancerrelated death; 1,3 therefore, it is important to explore novel biomarkers that can be used for targeted therapy in NSCLC.
KIAA0247 expression is suggested to be regulated by the tumor suppressor p53 and thus may be involved in carcinogenesis.
Previous studies have shown that low KIAA0247 mRNA levels in feces strongly correlate with colorectal tumor size and poor prognosis 12 and that KIAA0247 expression inversely correlates with tumor stage in ovarian cancer 11 and histological grade in glioma. 13 Therefore, we hypothesized that KIAA0247 may also play an important role in the progression of NSCLC. To the best of our knowledge, this is the first demonstration of a correlation between KIAA0247 expression and clinicopathological features of NSCLC.
We showed that high KIAA0247 expression positively correlated with cancer cell differentiation and survival of NSCLC patients, while negatively correlating with lymph node metastasis and p-TNM stage, suggesting that increased KIAA0247 levels can predict a better outcome. Investigation of the underlying mechanisms using cultured NSCLC cells showed that KIAA0247 reduced cancer cell migration, invasion, and proliferation by regulating the expression of functional proteins influencing the malignant behavior of tumor cells.
The Rho family of GTPases comprises RhoA, RhoB, and RhoC, which regulate cell migration and adhesion. [15] [16] [17] 27 In our study, KIAA0247 suppressed cell migration and invasion by downregulating RhoA, RhoC, and MMP9, and upregulating RhoB. Cell proliferation | 1063 depends on progression through the G1 phase of the cell cycle, requiring the activity of cyclin D-dependent kinase CDK4, 23, 24 which is negatively regulated by cyclin-dependent kinase inhibitors p16, p18, p21, and p27. 24, 28 Our results showed that KIAA0247 decreased the expression of cyclin D1 and increased that of p21,
suggesting that KIAA0247 inhibits cell proliferation by arresting the cell cycle at the G1/S transition point through regulation of the p21-cyclin D1-CDK4 axis.
Furthermore, KIAA0247 influenced the expression of several key EMT-related proteins: E-cadherin and claudin-1 were upregulated and N-cadherin, vimentin, Snail, and Twist1 were downregulated, suggesting a novel mechanism underlying the involvement of KIAA0247 in cancer. E-cadherin and N-cadherin are Ca 2+ -dependent adhesion molecules that play a central role in the regulation of cellcell interactions. 29 Upregulation of N-cadherin expression is linked to NSCLC metastasis, whereas its downregulation was shown to reduce NSCLC proliferation and invasion. 30 Snail and Twist1 are key transcription factors driving EMT and regulating cell adhesion and proliferation through Notch signaling. 31 The role of the Notch pathway in cancer, defined by its effects on cell proliferation, migration, and EMT, is well established.
31-33
Activation of Notch signaling occurs through the binding of a ligand such as Jagged1 to Notch receptors, which triggers downstream intracellular signaling events. Jagged1 is associated with multiple forms of cancer through its effects on cancer biology, including tumor cell growth, cancer stem cell maintenance, and metastasis. In our study, the expression of Jagged1 and NICD was downregulated by KIAA0247. NICD translocates to the nucleus, where it binds several transcription factors and modulates the expression of target genes, including those encoding Snail, E-cadherin, cyclin D1, c-Myc, and p21. 3 The c-secretase inhibitor DAPT blocks Notch signaling by reducing NICD formation, 10 which, in our case, was induced by KIAA0247 knockdown; consequently, DAPT partially suppressed cell migration, invasion, and proliferation, thus suggesting that KIAA0247, indeed, functions by regulating Notch signaling.
Our results indicate that KIAA0247 plays a critical role in NSCLC by inhibiting cancer cell proliferation and metastatic potential through the Notch signaling pathway, suggesting that KIAA0247 is a candidate prognostic biomarker and possible therapeutic target in NSCLC. Given that the Notch ligand Jagged1 not only participates in the Notch signaling pathway but also has other activities, further experiments should clarify whether Jagged1 mediates KIAA0247 effects through NCID and/or through Notch-independent mechanisms. 
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